FIBROLAMELLAR CARCINOMA
Clinical trials for FIBROLAMELLAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FIBROLAMELLAR CARCINOMA trials appear
Sign up with your email to follow new studies for FIBROLAMELLAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo hopes to fight tough childhood cancers
Disease control OngoingThis study tests a combination of two drugs, cobolimab and dostarlimab, in children and young adults (up to age 21) with advanced solid tumors that have not responded to other treatments. The goal is to find the safest dose and see if the drugs can shrink tumors. The study involv…
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New hope for kids with liver cancer: international trial tests smarter chemo
Disease control OngoingThis study tests different combinations of chemotherapy drugs in children and young adults with liver cancer (hepatoblastoma or hepatocellular carcinoma). The goal is to see which combinations work best alongside surgery to stop tumors from growing or spreading. About 537 partici…
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New immunotherapy combo shows promise in advanced cancers
Disease control OngoingThis early-phase study tests two experimental immunotherapy drugs (botensilimab and balstilimab) in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the best dose. About 499 participants with various can…
Matched conditions: FIBROLAMELLAR CARCINOMA
Phase: PHASE1 • Sponsor: Agenus Inc. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC